Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

Agile Therapeutics, Inc.

  • Al Altomari, Agile Therapeutics, Inc.

Agile Therapeutics, Inc. is a women's healthcare company dedicated to fulfilling the unmet health needs of today's women. The Company's lead product candidate, Twirla, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development.

  • Date:Tuesday, February 12
  • Time:10:30 AM - 10:45 AM
  • Room:Gramercy
  • Location:7th Floor
  • Session Type:Company Presentation
  • Submission ID:23618
  • Company Presentation - Presentation Type:Publicly Traded Company
  • Goal for Presentation:Increase Investor Awareness
  • Company Website:www.agiletherapeutics.com
  • Company HQ City:Princeton
  • Company HQ State:New Jersey
  • Company HQ Country:United States
  • Market Cap:~ $30 Million
  • Ticker:AGRX
  • Exchange:Nasdaq Capital Market
  • CEO/Top Company Official:Al Altomari
  • Year Founded:1997
  • Main Therapeutic Focus:Reproductive/Sexual Health
  • Lead Product in Development:Twirla, also known as AG200-15
  • Development Phase of Primary Product:Phase III
  • Number Of Unlicensed Products (For Which You Are Seeking Partners):None
Speakers
Al Altomari
Agile Therapeutics, Inc.
Back